floxuridine
Generic: floxuridine
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
floxuridine
Generic Name
floxuridine
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
Active Ingredients
floxuridine 500 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-145
Product ID
63323-145_a329ca66-d65a-4fd0-a2d9-b8e70ce3bcf8
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA075837
Listing Expiration
2026-12-31
Marketing Start
2001-03-15
Pharmacologic Class
Established (EPC)
Chemical Structure
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323145
Hyphenated Format
63323-145
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
floxuridine (source: ndc)
Generic Name
floxuridine (source: ndc)
Application Number
ANDA075837 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/5mL
Packaging
- 1 VIAL in 1 CARTON (63323-145-07) / 5 mL in 1 VIAL
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRA-ARTERIAL"], "spl_id": "a329ca66-d65a-4fd0-a2d9-b8e70ce3bcf8", "openfda": {"nui": ["N0000180853", "M0006020"], "unii": ["039LU44I5M"], "rxcui": ["310351"], "spl_set_id": ["c8edabc1-67cd-421b-a147-7c1f19f05b8e"], "pharm_class_cs": ["Deoxyuridine [CS]"], "pharm_class_epc": ["Antimetabolite [EPC]"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (63323-145-07) / 5 mL in 1 VIAL", "package_ndc": "63323-145-07", "marketing_start_date": "20010315"}], "brand_name": "Floxuridine", "product_id": "63323-145_a329ca66-d65a-4fd0-a2d9-b8e70ce3bcf8", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Antimetabolite [EPC]", "Deoxyuridine [CS]"], "product_ndc": "63323-145", "generic_name": "FLOXURIDINE", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Floxuridine", "active_ingredients": [{"name": "FLOXURIDINE", "strength": "500 mg/5mL"}], "application_number": "ANDA075837", "marketing_category": "ANDA", "marketing_start_date": "20010315", "listing_expiration_date": "20261231"}